SNHG33
gene geneOn this page
Also known as PAINT
Summary
SNHG33 (small nucleolar RNA host gene 33, HGNC:48575) is a unprocessed pseudogene on chromosome 3q27.1.
At a glance
- Gene type: non-coding (transcribed_unprocessed_pseudogene) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48575 |
| Approved symbol | SNHG33 |
| Name | small nucleolar RNA host gene 33 |
| Location | 3q27.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | PAINT |
| Ensembl gene | ENSG00000240024 |
| Ensembl biotype | transcribed_unprocessed_pseudogene |
| Entrez | 100505687 |
| RNAcentral | URS000075D97B — lncRNA, 1644 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 transcribed_unprocessed_pseudogene
ENST00000487386
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000487386 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001825264 | 183452371 | 183452485 |
| ENSE00001857517 | 183454015 | 183454093 |
| ENSE00001900699 | 183451741 | 183451822 |
| ENSE00001949081 | 183455191 | 183455335 |
Expression profiles
Bgee: expression breadth ubiquitous, 244 present calls, max score 93.15.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.3523 / max 67.3365, expressed in 1571 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 40102 | 5.0267 | 1464 |
| 40101 | 1.3256 | 735 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| Brodmann (1909) area 23 | UBERON:0013554 | 93.15 | gold quality |
| endothelial cell | CL:0000115 | 92.76 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 90.75 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 90.71 | gold quality |
| vastus lateralis | UBERON:0001379 | 90.60 | gold quality |
| biceps brachii | UBERON:0001507 | 90.57 | gold quality |
| adrenal tissue | UBERON:0018303 | 89.61 | gold quality |
| quadriceps femoris | UBERON:0001377 | 89.47 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 89.42 | gold quality |
| primary visual cortex | UBERON:0002436 | 89.08 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 88.70 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 88.69 | gold quality |
| nucleus accumbens | UBERON:0001882 | 88.47 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 88.44 | gold quality |
| left adrenal gland | UBERON:0001234 | 88.12 | gold quality |
| occipital lobe | UBERON:0002021 | 88.01 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 87.95 | gold quality |
| buccal mucosa cell | CL:0002336 | 87.95 | gold quality |
| cerebellar vermis | UBERON:0004720 | 87.92 | gold quality |
| adrenal gland | UBERON:0002369 | 87.87 | gold quality |
| hypothalamus | UBERON:0001898 | 87.85 | gold quality |
| right adrenal gland | UBERON:0001233 | 87.78 | gold quality |
| adrenal cortex | UBERON:0001235 | 87.66 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 87.48 | gold quality |
| heart right ventricle | UBERON:0002080 | 87.42 | gold quality |
| deltoid | UBERON:0001476 | 87.36 | gold quality |
| tibia | UBERON:0000979 | 86.90 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 86.83 | gold quality |
| pons | UBERON:0000988 | 86.61 | gold quality |
| substantia nigra | UBERON:0002038 | 86.57 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.10 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Long-chain non-coding RNA Linc00888 promotes the proliferation and migration of esophageal cancer cells by downregulating miR-34a expression. (PMID:33215424)
- LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC. (PMID:34472153)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.